Overcoming osteoporosis and beyond: Locomotive syndrome or dysmobility syndrome

We are presently facing ongoing global healthcare problems that are evolving to reflect the aging population. Musculoskeletal diseases are highly prevalent among elderly persons, and many of them have diverse complications. The impairment of the locomotive systemdconsisting of muscles, joints, carti...

Full description

Saved in:
Bibliographic Details
Published in:Osteoporosis and Sarcopenia Vol. 4; no. 3; pp. 77 - 78
Main Authors: Yi, Hyon-Seung, Lee, Sihoon
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01.09.2018
Korean Society of Osteoporosis
대한골다공증학회
Subjects:
ISSN:2405-5255, 2405-5263, 2405-5263
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract We are presently facing ongoing global healthcare problems that are evolving to reflect the aging population. Musculoskeletal diseases are highly prevalent among elderly persons, and many of them have diverse complications. The impairment of the locomotive systemdconsisting of muscles, joints, cartilage, bones including the spine, intervertebral discs, and nervesdis closely associated with a lower quality of life. In elderly people with locomotive syndrome (LS), hip fracture is the most serious complication of falling and a major cause of death in these people. In this issue, there is a paper of “Locomotive syndrome in Japan” by Ishibashi [1]. The author described that the Japanese Orthopaedic Association proposed the concept of LS in 2007, and recommended locomotion training for prevention and treatment of musculoskeletal diseases in aged patients. The author insists that these efforts will improve mobility and thus eventually reduce the demand for related medical care in elderly persons. In contrast to medical researchers in Japan, those in other countries, including Korea, have only paid attention to osteoporosis and bone metabolic diseases rather than the overall interaction of parts of skeletal system such as muscles and joints. However, Korea's population is also aging rapidly, and had already evolved from an “aging society” to an “aged society.” This is also true of many other parts of the world. Therefore, research is required to understand and prevent LS and dysmobility syndrome (DS). DS is proposed to be classified as three or more of the following 6 factors: osteoporosis, falls in the preceding year, obesity/high fat mass, low lean mass, slow gait speed, and low grip strength [2,3]. Recently, a study in Korea revealed that low peak jump power is associated with elevated odds of DS in community-dwelling elderly subjects, indicating that peak jump power may be also an important parameter for evaluating physical function in aged people. Therefore, the elderly people with low peak jump power should be educated to improve their muscle power [4]. In another study of 5994 men 65 years of age without hip arthroplasty who were able to walk without assistance, baseline DS was revealed to increase the risk of hip and other major osteoporotic fractures [5]. A study in Taiwan showed that patients with DS and pre-DS had a higher risk of mortality than the healthy control group [6]. The most important part of the therapeutic approach for overcoming DS is protein intake. For healthy adults, a daily protein intake of 0.7e0.8 g protein/kg body weight is recommended. Higher daily protein intakes of 1.0e1.2 and 1.2e1.5 g/kg body mass are recommended for the elderly and subjects with high risk of malnutrition, respectively. In addition, low water intake increases the risk of sarcopenia 1.5 fold, and thus it is helpful for people over 65 years old to drink 5 glasses or 1 L of water per day. These should be accompanied by regular exercise and physical activity in elderly individuals. Recently, the National Institute for Longevity Science in Japan has been promoting an exercise program called “cognicise” to prevent both cognitive dysfunction and DS. Although osteoporosis medications have been prescribed clinically for a long time to improve bone health, there are not yet any medicines that can effectively increase muscle mass. However, anabolic steroids, selective testosterone receptor modulators, and myostatin inhibitors have been investigated for improving muscle function in the elderly. In addition, research on molecular mechanisms of muscle-bone interaction have identified the importance of irisin, osteocalcin, b-aminoisobutyric acid, and prostaglandin E2 molecules, which could become targets of future therapies. Therefore, there is a strong possibility of new drug development for maintaining both muscle and bone health. In conclusion, holistic and multidisciplinary efforts are needed to improve the health and q... KCI Citation Count: 0
AbstractList We are presently facing ongoing global healthcare problems that are evolving to reflect the aging population. Musculoskeletal diseases are highly prevalent among elderly persons, and many of them have diverse complications. The impairment of the locomotive systemdconsisting of muscles, joints, cartilage, bones including the spine, intervertebral discs, and nervesdis closely associated with a lower quality of life. In elderly people with locomotive syndrome (LS), hip fracture is the most serious complication of falling and a major cause of death in these people. In this issue, there is a paper of “Locomotive syndrome in Japan” by Ishibashi [1]. The author described that the Japanese Orthopaedic Association proposed the concept of LS in 2007, and recommended locomotion training for prevention and treatment of musculoskeletal diseases in aged patients. The author insists that these efforts will improve mobility and thus eventually reduce the demand for related medical care in elderly persons. In contrast to medical researchers in Japan, those in other countries, including Korea, have only paid attention to osteoporosis and bone metabolic diseases rather than the overall interaction of parts of skeletal system such as muscles and joints. However, Korea's population is also aging rapidly, and had already evolved from an “aging society” to an “aged society.” This is also true of many other parts of the world. Therefore, research is required to understand and prevent LS and dysmobility syndrome (DS). DS is proposed to be classified as three or more of the following 6 factors: osteoporosis, falls in the preceding year, obesity/high fat mass, low lean mass, slow gait speed, and low grip strength [2,3]. Recently, a study in Korea revealed that low peak jump power is associated with elevated odds of DS in community-dwelling elderly subjects, indicating that peak jump power may be also an important parameter for evaluating physical function in aged people. Therefore, the elderly people with low peak jump power should be educated to improve their muscle power [4]. In another study of 5994 men 65 years of age without hip arthroplasty who were able to walk without assistance, baseline DS was revealed to increase the risk of hip and other major osteoporotic fractures [5]. A study in Taiwan showed that patients with DS and pre-DS had a higher risk of mortality than the healthy control group [6]. The most important part of the therapeutic approach for overcoming DS is protein intake. For healthy adults, a daily protein intake of 0.7e0.8 g protein/kg body weight is recommended. Higher daily protein intakes of 1.0e1.2 and 1.2e1.5 g/kg body mass are recommended for the elderly and subjects with high risk of malnutrition, respectively. In addition, low water intake increases the risk of sarcopenia 1.5 fold, and thus it is helpful for people over 65 years old to drink 5 glasses or 1 L of water per day. These should be accompanied by regular exercise and physical activity in elderly individuals. Recently, the National Institute for Longevity Science in Japan has been promoting an exercise program called “cognicise” to prevent both cognitive dysfunction and DS. Although osteoporosis medications have been prescribed clinically for a long time to improve bone health, there are not yet any medicines that can effectively increase muscle mass. However, anabolic steroids, selective testosterone receptor modulators, and myostatin inhibitors have been investigated for improving muscle function in the elderly. In addition, research on molecular mechanisms of muscle-bone interaction have identified the importance of irisin, osteocalcin, b-aminoisobutyric acid, and prostaglandin E2 molecules, which could become targets of future therapies. Therefore, there is a strong possibility of new drug development for maintaining both muscle and bone health. In conclusion, holistic and multidisciplinary efforts are needed to improve the health and q... KCI Citation Count: 0
Author Yi, Hyon-Seung
Lee, Sihoon
AuthorAffiliation Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
Department of Internal Medicine, Gachon University School of Medicine, Incheon, Korea
AuthorAffiliation_xml – name: Department of Internal Medicine, Gachon University School of Medicine, Incheon, Korea
– name: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
Author_xml – sequence: 1
  givenname: Hyon-Seung
  surname: Yi
  fullname: Yi, Hyon-Seung
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea
– sequence: 2
  givenname: Sihoon
  surname: Lee
  fullname: Lee, Sihoon
  email: shleemd@gachon.ac.kr
  organization: Department of Internal Medicine, Gachon University School of Medicine, Incheon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30775547$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002409478$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kUtr3DAUhUVJadI0f6CL4mWzGFcPS5azKITQR2BgoKRroZdTZWzdqeQZ8L-vJpMMbRdZ3Yv0nXPgnrfoJEL0CL0nuCaYiE8Pte4h1xQTWeOuxpi8Qme0wXzBqWAnx53zU3SRczC4aVrOaSveoFOG27I37RlarXY-WRhDvK8gTx42kCCHXOnoKuNniO6qWkIhYAo7X-U5ugSjryBVbs4jmDCEaT6-v0Ovez1kf_E0z9HPr1_ubr4vlqtvtzfXy4VlnSQLz5xuuO6kw5KanrZc-M5QpokkRhptGbM9tZph2jvSSttqRp3rhDEtxliwc3R58I2pV2sbFOjwOO9BrZO6_nF3q5gUnIu2sJ8P7GZrRu-sj1PSg9qkMOo0Pyr__YnhV_HZKcEE7URXDD4-GST4vfV5UmPI1g-Djh62WVEiGZFcyKagH_7OOoY8X7wA8gDYcuecfK9smPQUYB8dBkWw2verHtS-X7XvV-FOlX6LlP4nfXZ_UXR1EPnSxi74pOwQYrB6WPtZOQgvif8A4RW_iA
CitedBy_id crossref_primary_10_1007_s00198_020_05591_x
crossref_primary_10_7717_peerj_9026
crossref_primary_10_3390_jcm11030610
crossref_primary_10_3390_s24237727
crossref_primary_10_3390_jcm13051385
crossref_primary_10_3390_jcm10112464
Cites_doi 10.1007/s00198-013-2427-1
10.1016/j.afos.2018.09.004
10.2147/CIA.S102961
10.1002/jbmr.3455
10.1007/s00198-018-4466-0
10.1038/s41598-017-09366-z
ContentType Journal Article
Copyright 2018
2018 Published by Elsevier Ltd. 2018
Copyright_xml – notice: 2018
– notice: 2018 Published by Elsevier Ltd. 2018
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.1016/j.afos.2018.09.001
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2405-5263
EndPage 78
ExternalDocumentID oai_kci_go_kr_ARTI_3865567
PMC6362969
30775547
10_1016_j_afos_2018_09_001
S2405525518300736
Genre Editorial
Commentary
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
M~E
AAYXX
CITATION
.1-
.FO
0R~
0SF
457
5VS
6I.
AACTN
AAEDW
AAFTH
AALRI
AAXUO
ABMAC
ACGFS
ADBBV
ADEZE
ADVLN
AEXQZ
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
AKRWK
AMRAJ
AOIJS
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IPNFZ
KQ8
NCXOZ
NPM
O9-
OK1
RIG
ROL
RPM
SSZ
Z5R
7X8
AAYWO
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
5PM
ACYCR
ID FETCH-LOGICAL-c3981-e3da45a98d082bf2756e9b23a181b8bac33cf2ca302fd178c7a32dd96bb700063
ISSN 2405-5255
2405-5263
IngestDate Tue Nov 21 21:41:50 EST 2023
Tue Nov 04 02:00:40 EST 2025
Sun Nov 09 13:11:02 EST 2025
Thu Jan 02 23:01:01 EST 2025
Sat Nov 29 04:00:25 EST 2025
Tue Nov 18 22:18:51 EST 2025
Tue Aug 26 18:47:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License This is an open access article under the CC BY-NC-ND license.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3981-e3da45a98d082bf2756e9b23a181b8bac33cf2ca302fd178c7a32dd96bb700063
Notes SourceType-Scholarly Journals-1
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
OpenAccessLink http://dx.doi.org/10.1016/j.afos.2018.09.001
PMID 30775547
PQID 2183185684
PQPubID 23479
PageCount 2
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_3865567
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6362969
proquest_miscellaneous_2183185684
pubmed_primary_30775547
crossref_citationtrail_10_1016_j_afos_2018_09_001
crossref_primary_10_1016_j_afos_2018_09_001
elsevier_clinicalkey_doi_10_1016_j_afos_2018_09_001
PublicationCentury 2000
PublicationDate September 2018
2018-09-00
2018-Sep
20180901
2018-09
PublicationDateYYYYMMDD 2018-09-01
PublicationDate_xml – month: 09
  year: 2018
  text: September 2018
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Osteoporosis and Sarcopenia
PublicationTitleAlternate Osteoporos Sarcopenia
PublicationYear 2018
Publisher Elsevier B.V
Korean Society of Osteoporosis
대한골다공증학회
Publisher_xml – name: Elsevier B.V
– name: Korean Society of Osteoporosis
– name: 대한골다공증학회
References Ishibashi (bib1) 2018; 4
Lee, Liu, Hwang, Peng, Lin, Chen (bib6) 2017; 7
Binkley, Krueger, Buehring (bib2) 2013; 24
Buehring, Hansen, Lewis, Cummings, Lane, Binkley (bib5) 2018; 33
Hong, Kim, Youm, Kim, Rhee (bib4) 2018; 29
Hill, Farrier, Russell, Burton (bib3) 2017; 12
Hill (10.1016/j.afos.2018.09.001_bib3) 2017; 12
Hong (10.1016/j.afos.2018.09.001_bib4) 2018; 29
Buehring (10.1016/j.afos.2018.09.001_bib5) 2018; 33
Lee (10.1016/j.afos.2018.09.001_bib6) 2017; 7
Binkley (10.1016/j.afos.2018.09.001_bib2) 2013; 24
Ishibashi (10.1016/j.afos.2018.09.001_bib1) 2018; 4
References_xml – volume: 33
  start-page: 1622
  year: 2018
  end-page: 1629
  ident: bib5
  article-title: Dysmobility syndrome independently increases fracture risk in the osteoporotic fractures in men (MrOS) prospective cohort study
  publication-title: J Bone Miner Res
– volume: 4
  year: 2018
  ident: bib1
  article-title: Locomotive syndrome in Japan
  publication-title: Osteoporos Sarcopenia
– volume: 7
  start-page: 8785
  year: 2017
  ident: bib6
  article-title: Dysmobility syndrome and risk of mortality for community-dwelling middle-aged and older adults: the nexus of aging and body composition
  publication-title: Sci Rep
– volume: 29
  start-page: 1427
  year: 2018
  end-page: 1436
  ident: bib4
  article-title: Low peak jump power is associated with elevated odds of dysmobility syndrome in community-dwelling elderly individuals: the Korean Urban Rural Elderly (KURE) study
  publication-title: Osteoporos Int
– volume: 12
  start-page: 145
  year: 2017
  end-page: 152
  ident: bib3
  article-title: Dysmobility syndrome: current perspectives
  publication-title: Clin Interv Aging
– volume: 24
  start-page: 2955
  year: 2013
  end-page: 2959
  ident: bib2
  article-title: What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?
  publication-title: Osteoporos Int
– volume: 24
  start-page: 2955
  year: 2013
  ident: 10.1016/j.afos.2018.09.001_bib2
  article-title: What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-013-2427-1
– volume: 4
  issue: 3
  year: 2018
  ident: 10.1016/j.afos.2018.09.001_bib1
  article-title: Locomotive syndrome in Japan
  publication-title: Osteoporos Sarcopenia
  doi: 10.1016/j.afos.2018.09.004
– volume: 12
  start-page: 145
  year: 2017
  ident: 10.1016/j.afos.2018.09.001_bib3
  article-title: Dysmobility syndrome: current perspectives
  publication-title: Clin Interv Aging
  doi: 10.2147/CIA.S102961
– volume: 33
  start-page: 1622
  year: 2018
  ident: 10.1016/j.afos.2018.09.001_bib5
  article-title: Dysmobility syndrome independently increases fracture risk in the osteoporotic fractures in men (MrOS) prospective cohort study
  publication-title: J Bone Miner Res
  doi: 10.1002/jbmr.3455
– volume: 29
  start-page: 1427
  year: 2018
  ident: 10.1016/j.afos.2018.09.001_bib4
  article-title: Low peak jump power is associated with elevated odds of dysmobility syndrome in community-dwelling elderly individuals: the Korean Urban Rural Elderly (KURE) study
  publication-title: Osteoporos Int
  doi: 10.1007/s00198-018-4466-0
– volume: 7
  start-page: 8785
  year: 2017
  ident: 10.1016/j.afos.2018.09.001_bib6
  article-title: Dysmobility syndrome and risk of mortality for community-dwelling middle-aged and older adults: the nexus of aging and body composition
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-09366-z
SSID ssib044755276
ssj0001562622
Score 2.039087
Snippet We are presently facing ongoing global healthcare problems that are evolving to reflect the aging population. Musculoskeletal diseases are highly prevalent...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 77
SubjectTerms 정형외과학
Title Overcoming osteoporosis and beyond: Locomotive syndrome or dysmobility syndrome
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2405525518300736
https://www.ncbi.nlm.nih.gov/pubmed/30775547
https://www.proquest.com/docview/2183185684
https://pubmed.ncbi.nlm.nih.gov/PMC6362969
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002409478
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Osteoporosis and Sarcopenia, 2018, 4(3), 13, pp.77-78
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2405-5263
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001562622
  issn: 2405-5255
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2405-5263
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssib044755276
  issn: 2405-5255
  databaseCode: M~E
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfoQNMuE990wBQQN5SpsZPY5obQEEhsRdqQysnyV1g2llTtOm0X_naeYyfNyjbBgYtbOc5z5N_L87Pz_HsIvdHMYJYbHTMFRcphuaN4pmJNMlVoLoliPtkE3d9nkwn_GnK1z5t0ArSq2MUFn_5XqKEOwHZHZ_8B7k4oVMB_AB1KgB3KvwJ-DE8McptoZoCwBge7dqwjbodcNedV3C7Al1o3cXjntiMtcKHp5nJ-WjfxspfXkhmMVyXOYfRcBq6yM-_ffR5s6Cg-sIswMS5Dfg7KozqoQthsSFgXTQVzRWOUwAHIYPEajFKwoGlPUUjPGvoELX8Yab9fcLwji9oRpidsx5OG9hvDSExPG4SII-nLPC3nCjV2e2mA7mKacd5bUYdD4jjHOByV8lF9q31uoPVWyk2eyaCaFdetP1bDaHt-yeF9tBkWFNF7rwgP0B1bPUTreyFk4hEaL_Uh6utDBOhFXh_eRUttiFrUo3oW9bShq3-Mvn3cPfzwKQ5ZNOB94yyJLTEyzSRnBrw9VTi6f8sVJhJ8O8WU1IToAmtJRrgwCWWaSoKN4blStPFgn6C1qq7sMxQVChuLbWZGmUlTQllCqBxJQ0B6kXI7REk7gkIHinmX6eSnaGMJj4UDQDgAxIi7gMohetvdM_UEK7e2Ji0woj06DJOdANW69a7XgKE40aVwbOru90ctTmYC1oyfhct6m-V0iF61EAswse67maxsvQBJMO2BW5uzdIieesi7R22VZ4joFWXoGrgOr16pyqOGxj0H35HnfOtGmc_RxvIdfIHWzmYL-xLd0-dn5Xy2jQZ0wrYbjYdy79fub30RufY
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overcoming+osteoporosis+and+beyond%3A+Locomotive+syndrome+or+dysmobility+syndrome&rft.jtitle=Osteoporosis+and+sarcopenia&rft.au=Yi%2C+Hyon-Seung&rft.au=Lee%2C+Sihoon&rft.date=2018-09-01&rft.eissn=2405-5263&rft.volume=4&rft.issue=3&rft.spage=77&rft_id=info:doi/10.1016%2Fj.afos.2018.09.001&rft_id=info%3Apmid%2F30775547&rft.externalDocID=30775547
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-5255&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-5255&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-5255&client=summon